Delta variant infecting mounting number of people in rural Kansas and Missouri
The delta coronavirus variant is infecting a mounting number of people in rural Kansas and Missouri.
Related Articles
Desmoplastic Melanoma: 5-Minute Pathology Pearls
A complete organized library of all my videos, digital slides, pics, & sample pathology reports is available here: https://kikoxp.com/posts/5084 (dermpath) &…
Texas teen accused of poisoning show goat of classmate she believed cheated
The 17-year-old allegedly admitted to police that she poisoned the goat because its owner was “a cheater” and she “doesn’t like cheaters,” the affidavit said.
Monica Bertagnolli: I recently welcomed Secretary of the Interior Deb Haaland to NIH – OncoDaily
Monica Bertagnolli: I recently welcomed Secretary of the Interior Deb Haaland to NIH / cancer, Deb Haaland, Federal Indian Boarding School Healing Summit,
Scrubs “My Musical” – Everything Comes Down to Poo
This is the 3rd song from Scrubs “My Musical” Everything Comes Down to Poo
The new NCCN guidelines for immunotherapy-related toxicities – OncoDaily
The new NCCN guidelines for immunotherapy-related toxicities / cancer, CAR T-cell therapy, Elvina Almuradova, European School of Oncology, fight against
Paolo Tarantino: PostMONARCH is out in Journal of Clinical Oncology – OncoDaily
Paolo Tarantino: PostMONARCH is out in Journal of Clinical Oncology / Breast Cancer, cancer, Erika Hamilton, Fulvestrant and Abemaciclib, Giampaolo Bianchini,
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial – OncoDaily
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial / Avelumab, axitinib, cancer, ESMO Annals of Oncology, Javelin Renal 101 trial, OncoDaily,
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers? – OncoDaily
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers? / cancer, muscle health, OncoDaily, Oncology, Sami (Papacek) Mansfield
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer – OncoDaily
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer / cancer, dMMR/MSI-H Rectal Cancer, Dostarlimab, FDA, OncoDaily, Oncology,
Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics – OncoDaily
Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics / Alvaro Sebastian, Aurélien Marabelle, cancer,